Skip to content
OpenCapital
Get started

Adaptive Biotechnologies ADPT Invested capital

Discontinued — last reported Q1 '26

Invested capital at other companies

Griffon logo
GriffonGFF
5.9%-9.9pp
Benchmark Electronics logo
Benchmark ElectronicsBHE
3.8%-1.7pp
NovoCure logo
NovoCureNVCR
-65.8%+73.8pp
Power Integrations logo
Power IntegrationsPOWI
1.5%-1.0pp
Hayward Holdings logo
Hayward HoldingsHAYW
8.3%+0.8pp
Chemours logo
ChemoursCC
-0.6%-4.1pp

Other financials

Income statement

See full
Revenue$70.9M+35.1%
Gross profit$52.2M+47.1%
Operating income-$19.2M+35.1%
Net income-$20.0M+32.9%
EPS (diluted)-$0.13+35.0%

Balance sheet

See full
Cash & equivalents$77.6M+53.2%
Total debt$208.2M-5.6%
Total equity$216.3M+13.6%
Total assets$505.9M-1.0%

Cash flow

See full
Operating cash flow-$9.5M+66.5%
CapEx$796.0K-36.8%
Free cash flow-$10.3M+65.3%

Valuation

See full
Market cap$2.76B+93.6%
Enterprise value$2.89B+78.0%
P/S9.3×+1.8×

Profitability

See full
Gross margin75.3%+12.7pp
Operating margin-15.8%-7.0pp
Net margin-16.8%-7.3pp
FCF margin-10.5%-4.6pp

Returns & leverage

See full
Return on equity-24.4%-9.2pp
Debt / equity1×-0.2×
Current ratio3.4×+0.4×

Where this comes from

Calculated from Adaptive Biotechnologies’s reported figures.

$208.2Mtotal debt+$216.3Mtotal stockholders equity−$77.6Mcash and equivalents=$346.94M

The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Adaptive Biotechnologies's invested capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Adaptive Biotechnologies's invested capital?
Adaptive Biotechnologies (ADPT) reported invested capital of $346.94M in Q1 2026.
How has Adaptive Biotechnologies's invested capital changed year-over-year?
Adaptive Biotechnologies's invested capital decreased by 3.7% year-over-year, from $360.24M to $346.94M.
What is the long-term trend for Adaptive Biotechnologies's invested capital?
Over 5 years (2020 to 2025), Adaptive Biotechnologies's invested capital has grown at a -13.2% compound annual growth rate (CAGR), from $727.69M to $358.65M.
What does invested capital mean?
Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).